A Phase I Study of the Safety and Pharmacokinetics of Recombinant Human CD4-Immunoglobulin G (rCD4-IgG) Administered by Intravenous Bolus Injection in Combination With Oral Zidovudine in Patients With AIDS and AIDS-Related Complex
Phase of Trial: Phase I
Latest Information Update: 29 Oct 2014
At a glance
- Drugs CD4 IgG (Primary) ; Zidovudine
- Indications HIV infections
- Focus Adverse reactions; Pharmacokinetics
- 05 Nov 2010 New trial record.